151 related articles for article (PubMed ID: 16009516)
1. Calorimetric determination of amorphous content in lactose: a note on the preparation of calibration curves.
Ramos R; Gaisford S; Buckton G
Int J Pharm; 2005 Aug; 300(1-2):13-21. PubMed ID: 16009516
[TBL] [Abstract][Full Text] [Related]
2. Approaches to determine the enthalpy of crystallisation, and amorphous content, of lactose from isothermal calorimetric data.
Dilworth SE; Buckton G; Gaisford S; Ramos R
Int J Pharm; 2004 Oct; 284(1-2):83-94. PubMed ID: 15454300
[TBL] [Abstract][Full Text] [Related]
3. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
Timmermann IL; Steckel H; Trunk M
Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
[TBL] [Abstract][Full Text] [Related]
4. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
[TBL] [Abstract][Full Text] [Related]
5. The quantification of small degrees of disorder in lactose using solution calorimetry.
Hogan SE; Buckton G
Int J Pharm; 2000 Oct; 207(1-2):57-64. PubMed ID: 11036230
[TBL] [Abstract][Full Text] [Related]
6. Determination of amorphous content of lactose samples by solution calorimetry.
Harjunen P; Lehto VP; Koivisto M; Levonen E; Paronen P; Järvinen K
Drug Dev Ind Pharm; 2004 Sep; 30(8):809-15. PubMed ID: 15521327
[TBL] [Abstract][Full Text] [Related]
7. Use of heat of adsorption to quantify amorphous content in milled pharmaceutical powders.
Alam S; Omar M; Gaisford S
Int J Pharm; 2014 Jan; 459(1-2):19-22. PubMed ID: 24315924
[TBL] [Abstract][Full Text] [Related]
8. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples.
Saunders M; Podluii K; Shergill S; Buckton G; Royall P
Int J Pharm; 2004 Apr; 274(1-2):35-40. PubMed ID: 15072780
[TBL] [Abstract][Full Text] [Related]
9. Determination of amorphous content in the pharmaceutical process environment.
Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
[TBL] [Abstract][Full Text] [Related]
10. Limitations of amorphous content quantification by isothermal calorimetry using saturated salt solutions to control relative humidity: alternative methods.
Khalef N; Pinal R; Bakri A
J Pharm Sci; 2010 Apr; 99(4):2080-9. PubMed ID: 19774655
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of amorphous content of lactose using CCD-Raman spectroscopy.
Niemelä P; Päällysaho M; Harjunen P; Koivisto M; Lehto VP; Suhonen J; Järvinen K
J Pharm Biomed Anal; 2005 Apr; 37(5):907-11. PubMed ID: 15862665
[TBL] [Abstract][Full Text] [Related]
12. Isothermal microcalorimetry for quantifying amorphous content in processed pharmaceuticals.
Gaisford S
Adv Drug Deliv Rev; 2012 Apr; 64(5):431-9. PubMed ID: 22100528
[TBL] [Abstract][Full Text] [Related]
13. Moisture sorption, compressibility and caking of lactose polymorphs.
Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the amorphous content of lactose by solution calorimetry and Raman spectroscopy.
Katainen E; Niemelä P; Harjunen P; Suhonen J; Järvinen K
Talanta; 2005 Nov; 68(1):1-5. PubMed ID: 18970276
[TBL] [Abstract][Full Text] [Related]
15. The application of near infrared spectroscopy and dynamic vapor sorption to quantify low amorphous contents of crystalline lactose.
Hogan SE; Buckton G
Pharm Res; 2001 Jan; 18(1):112-6. PubMed ID: 11336345
[TBL] [Abstract][Full Text] [Related]
16. Application and use of isothermal calorimetry in pharmaceutical development.
O'Neill MA; Gaisford S
Int J Pharm; 2011 Sep; 417(1-2):83-93. PubMed ID: 21277961
[TBL] [Abstract][Full Text] [Related]
17. The effects of high shear blending on alpha-lactose monohydrate.
Bridson RH; Robbins PT; Chen Y; Westerman D; Gillham CR; Roche TC; Seville JP
Int J Pharm; 2007 Jul; 339(1-2):84-90. PubMed ID: 17398047
[TBL] [Abstract][Full Text] [Related]
18. Application of surface area measurement for identifying the source of batch-to-batch variation in processability.
Vippagunta RR; Pan C; Vakil R; Meda V; Vivilecchia R; Motto M
Pharm Dev Technol; 2009; 14(5):492-8. PubMed ID: 19241221
[TBL] [Abstract][Full Text] [Related]
19. Stability assessment of pharmaceuticals by isothermal calorimetry: two component systems.
Skaria CV; Gaisford S; O'Neill MA; Buckton G; Beezer AE
Int J Pharm; 2005 Mar; 292(1-2):127-35. PubMed ID: 15725559
[TBL] [Abstract][Full Text] [Related]
20. Compaction of crystallographic forms of pharmaceutical granular lactoses. I. Compressibility.
Busignies V; Tchoreloff P; Leclerc B; Besnard M; Couarraze G
Eur J Pharm Biopharm; 2004 Nov; 58(3):569-76. PubMed ID: 15451531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
